Physician

Amish V. Patel, MD

According to 2025 Medicare claims, Amish Patel, MD (NPI: 1932384955) practices geriatric medicine in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is RALEIGH MEDICAL GROUP, PA (NPI: 1104962315; TIN: 561166754) and primary practice location at 27615-4320. Patel is affiliated with the The Accountable Care Organization, Ltd. (ACO ID: A2098), participating under the MSSP model.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 436 traditional Medicare patients, billed 2,232 HCPCS/CPT codes, and received $152,613 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 16,377 prescription claims across 668 beneficiaries totaling $1,071,971 in drug costs, led by Eliquis (Apixaban). DME data shows 361 claims. Open Payments data shows 9 records totaling $176. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $404,843 to $1,071,971. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $11,618 and ending at $957,752.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$76K$153K2015 Medicare payment: $123,016 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $107,606 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $109,236 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $129,308 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $139,252 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $117,813 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $95,652 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $96,805 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $137,955 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $152,613 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154751,828$123,016
20164511,287$107,606
20174401,318$109,236
20184331,527$129,308
20195341,634$139,252
20205271,281$117,813
20214251,086$95,652
20224921,180$96,805
20233841,976$137,955
20244362,232$152,613

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$536K$1.1M2015 Drug cost: $404,843 (USD; Tot_Drug_Cst)2016 Drug cost: $472,270 (USD; Tot_Drug_Cst)2017 Drug cost: $513,549 (USD; Tot_Drug_Cst)2018 Drug cost: $548,450 (USD; Tot_Drug_Cst)2019 Drug cost: $618,702 (USD; Tot_Drug_Cst)2020 Drug cost: $998,620 (USD; Tot_Drug_Cst)2021 Drug cost: $882,637 (USD; Tot_Drug_Cst)2022 Drug cost: $651,885 (USD; Tot_Drug_Cst)2023 Drug cost: $819,292 (USD; Tot_Drug_Cst)2024 Drug cost: $1,071,971 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154188,266$404,843
20163669,586$472,270
201731610,971$513,549
201827511,824$548,450
201935920,537$618,702
202043527,229$998,620
202139615,411$882,637
202256611,918$651,885
202363311,806$819,292
202466816,377$1,071,971

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$473K$946K2015 Medicare payment: $8,050 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $7,827 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $1,417 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $2,220 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $16,923 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $15,210 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $934 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $593 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $945,957 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201525180$8,050
201611167$7,827
2017N/R61$1,417
2018N/R68$2,220
201912148$16,923
202023189$15,210
2021N/RN/RN/R
2022N/R72$934
2023N/R17$593
2024312361$945,957

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more134193$131
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more7575$119
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more265623$88
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more274675$58
99497Advance care planning, first 30 minutes6173$55

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban52212,503$253,269
NuplazidPimavanserin Tartrate36496$87,604
JardianceEmpagliflozin1172,607$55,107
XareltoRivaroxaban1292,691$52,010
MyrbetriqMirabegron881,816$28,764

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A6197Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressingN119119$753,684
A4239Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of serviceN101101$169,625
E2103Non-adjunctive, non-implanted continuous glucose monitor or receiverN9292$21,550
K0004High strength, lightweight wheelchairYN/R15$503
K0003Lightweight wheelchairYN/R17$446

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$176Novo Nordisk Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Amish V. Patel, MD?

Tedicare shows public-source Medicare data for Amish V. Patel, MD (NPI 1932384955), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amish V. Patel, MD have ACO affiliation data?

Amish V. Patel, MD is shown with ACO affiliation data for The Accountable Care Organization, Ltd. (MSSP, ACO ID A2098).

What billing organization is linked to Amish V. Patel, MD?

Amish V. Patel, MD is linked to RALEIGH MEDICAL GROUP, PA (billing NPI 1104962315) in the available physician profile data.

Does Amish V. Patel, MD have Open Payments data?

Amish V. Patel, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.